Conformational toxicity and sporadic conformational diseases

被引:12
|
作者
Reiss, C [1 ]
Lesnik, T
Parvez, H
Parvez, S
Ehrlich, R
机构
[1] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France
[2] Inst Alfred Fessard, CNRS, F-91198 Gif Sur Yvette, France
[3] Univ Republ, Fac Ciencias, Secc Bioquim, Montevideo 11400, Uruguay
关键词
conformational toxicity; conformational diseases; protein misfolding;
D O I
10.1016/S0300-483X(00)00308-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Spontaneous, so-called 'conformational' diseases, specially of the neurodegenerative type like Alzheimer's, are linked to certain protein types which have the normal amino-acid sequence but are misfolded and accumulate due to resistance to proteolysis. In the case of prion diseases, the 'protein only' hypothesis assumes that the misconformation of a native protein could be initiated upon interaction with a sister-protein already in the misfolded stare. There is an alternative to this sister protein contamination scheme, which assumes that the misconformation is acquired upon protein synthesis, that is de novo. Misfoldling and resistance to proteolysis could result from defects responsible for shortage or inactivity of the cellular factors in charge of protein folding and degradation. The defects could have a genetic origin (the gene of the faulty factor involved could have been mutated, or control and regulation of its expression could have been altered, etc.). Alternatively, the cell's actual biosynthetic and/or proteolytic resources could have become overloaded and unavailable, due to unscheduled mass-production of proteins resulting from unscheduled cell growth or proliferation, cell stress, etc. Xenobiotics, active for instance as endocrine proliferators, stressors, or inducing copious, unscheduled gene expression, etc. could give rise to shortage of cellular factors necessary for the production of native proteins and for proteolysis. Alternatively, xenobiotics could alter expression or activity of some of these factors. In both cases, the xenobiotic could be a 'conformational toxicant' by inducing misfolding of selected proteins. The xenobiotic could trigger some conformational disease if it targets a specific protein and tissue. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 50 条
  • [31] Conformational Diseases: Structural Studies of Aggregation of Polyglutamine Proteins
    Papaleo, Elena
    Invernizzi, Gaetano
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2011, 7 (01) : 23 - 43
  • [32] Artificial DnaJ Protein for protein production and conformational diseases
    Hishiya, Akinori
    Koya, Keizo
    SCIENTIFIC REPORTS, 2017, 7
  • [33] Promiscuous beta-strand interactions and the conformational diseases
    Chow, MKM
    Lomas, DA
    Bottomley, SP
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (04) : 491 - 499
  • [34] PHARMACOPERONES AS NOVEL THERAPEUTICS FOR DIVERSE PROTEIN CONFORMATIONAL DISEASES
    Tao, Ya-Xiong
    Conn, P. Michael
    PHYSIOLOGICAL REVIEWS, 2018, 98 (02) : 697 - 725
  • [35] Dominant protein interactions that influence the pathogenesis of conformational diseases
    Wright, Jordan
    Wang, Xiaofan
    Haataja, Leena
    Kellogg, Aaron R.
    Lee, Jaemin
    Liu, Ming
    Arvan, Peter
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (07): : 3124 - 3134
  • [36] Artificial DnaJ Protein for protein production and conformational diseases
    Akinori Hishiya
    Keizo Koya
    Scientific Reports, 7
  • [37] Pharmacological chaperones: a potential therapeutic treatment for conformational diseases
    Mendre, Christiane
    Mouillac, Bernard
    M S-MEDECINE SCIENCES, 2010, 26 (6-7): : 627 - 635
  • [38] Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
    Soto, Claudio
    Pritzkow, Sandra
    NATURE NEUROSCIENCE, 2018, 21 (10) : 1332 - 1340
  • [39] Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
    Claudio Soto
    Sandra Pritzkow
    Nature Neuroscience, 2018, 21 : 1332 - 1340
  • [40] Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases
    Li, Dan
    Liu, Cong
    NATURE REVIEWS NEUROSCIENCE, 2022, 23 (09) : 523 - 534